ELEISON PHARMACEUTICALS
Eleison Pharmaceuticals acquires, develops, and commercializes clinical stage drug candidates for "orphan" cancers.
ELEISON PHARMACEUTICALS
Social Links:
Industry:
Health Care Medical Pharmaceutical
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.eleison-pharma.com
Total Employee:
1+
Status:
Active
Contact:
215-554-3530
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache IPv6 PHP
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
BioNumerik Pharmaceuticals
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
California Artisanal Medicine
California Artisanal Medicine, or CAM, is a cannabis retailer and cultivator based in Sacramento, California.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Dova Pharmaceuticals
Dova Pharmaceuticals focused on acquiring, developing and commercializing drug candidates.
Fabre-Kramer Pharmaceuticals
Fabre-Kramer Pharmaceuticals was formed to identify, develop and commercialize psychotropic drugs with significant market potential.
Galt Pharmaceuticals
Galt Pharmaceuticals expertize in enhancing the lives of patients, entrepreneurs & communities by transforming the pharmaceutical industry.
Avita Pharmacy
Avita is a national pharmacy services and solutions provider with a passion for community support and advocacy.
NUCRYST Pharmaceuticals
NUCRYST Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using
Pharmadva
PharmAdva develops a product that delivers improved quality of life for patients.
RemedyOne
RemedyOne helps patients, employers, drug companies, insurers and pharmacies for healthcare outcomes.
USS Vision
USS Vision designs, develops, manufactures, and integrates vision-based products and services to increase quality and reduce costs.
Velesco Pharmaceutical
Velesco focuses on formulation and early stage drug development in pharmaceuticals.
Founder
Official Site Inspections
http://www.eleison-pharma.com Semrush global rank: 5.77 M Semrush visits lastest month: 1.45 K
- Host name: az1-ss44.a2hosting.com
- IP address: 68.66.226.109
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Eleison Pharmaceuticals"
Team – Eleison Pharmaceuticals
Prior to founding Eleison in 2009, Mr. Thomas was chief operating officer of Provid Pharmaceuticals, a company engaged in the discovery and development of autoimmune …See details»
Eleison Pharmaceuticals - Crunchbase Company Profile & Funding
Eleison Pharmaceuticals acquires, develops, and commercializes clinical stage drug candidates for cancer patients. Search Crunchbase. Start Free Trial . Chrome Extension. ... Contact Email …See details»
Eleison Pharmaceuticals Inc - Company Profile and News
Eleison Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on acquiring, developing, and commercializing clinical stage drug candidates for orphan cancers.See details»
Eleison Pharmaceuticals Inc. - LinkedIn
Eleison Pharmaceuticals Inc. is a biopharmaceutical company based out of 100 Overlook Center, Princeton, NJ, United States.See details»
Eleison Pharmaceuticals - PitchBook
Eleison Pharmaceuticals General Information Description. Developer of a specialty pharmaceuticals and life-saving drugs intended for cancer treatment. The company acquires, develops and commercializes clinical-stage drug …See details»
Eleison Pharmaceuticals - Overview, News & Similar companies
Eleison Pharmaceuticals contact info: Phone number: (215) 554-3530 Website: www.eleison-pharma.com What does Eleison Pharmaceuticals do? Eleison Pharmaceuticals is a clinical …See details»
CEO & President at Eleison Pharmaceuticals - The Org
Prior to founding Eleison in 2009, Mr. Thomas was chief operating officer of Provid Pharmaceuticals, a company engaged in the discovery and development of autoimmune …See details»
Eleison Pharmaceuticals - Craft
Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers. It is focused on the development of drug candidate ILC, a lipid …See details»
Eleison Pharmaceuticals - Products, Competitors, Financials, …
Eleison Pharmaceuticals is a biopharmaceutical company focused on developing therapies for rare and life-threatening cancers. Use the CB Insights Platform to explore Eleison …See details»
About Eleison – Eleison Pharmaceuticals
Eleison Pharmaceuticals 100 Overlook Center 2nd Floor Princeton NJ 08540 . 215-554-3530. [email protected] ...See details»
Eleison Pharmaceuticals LLC - BioCentury Company Profiles - BCIQ
Mar 25, 2019 Eleison Pharmaceuticals LLC - BioCentury Company Profiles for the biopharma industrySee details»
Windtree and Eleison Announce Initial Results of Delivering
Jun 4, 2019 Eleison was founded in 2009 and is headquartered in Princeton, NJ. Additional information about Eleison can be found at the Company's website www.eleison-pharma.com. …See details»
Eleison Pharmaceuticals: Betting On Late-Stage Candidates For …
Jan 28, 2022 Eleison Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company acquiring, developing and commercializing late-stage therapies that are in Phase II or Phase …See details»
Our Pipeline – Eleison Pharmaceuticals
Eleison Pharmaceuticals 100 Overlook Center 2nd Floor Princeton NJ 08540 . 215-554-3530. [email protected] ...See details»
Cancer biotech Eleison Pharmaceuticals withdraws $42 million IPO
Jun 29, 2023 Eleison Pharmaceuticals, a Phase 3 biotech developing in-licensed therapies for cancer, withdrew its plans for an initial public offering on Thursday. It originally filed in January …See details»
Cancer biotech Eleison Pharmaceuticals files for a $42 million IPO
Jan 24, 2022 Eleison's lead program, glufosfamide, was licensed from Threshold Pharmaceuticals in 2009 and is being developed for pancreatic cancer. Glufosfamide is …See details»
Orphan drug developer Eleison Pharmaceuticals files to hold IPO
Feb 24, 2022 A development stage company, Eleison reported a net loss of $2.7M with no revenue for 2021. Eleison intends to use proceeds from the IPO to help fund drug …See details»
Clinical Trials – Eleison Pharmaceuticals
Eleison Pharmaceuticals 100 Overlook Center 2nd Floor Princeton NJ 08540 . 215-554-3530. [email protected] ...See details»
Windtree, Eleison Announce Study Results of Delivering Inhaled …
Jun 4, 2019 Eleison has an exclusive worldwide license to ILC, a novel, sustained-release formulation of cisplatin in a nanoscale lipid-based complex administered via inhalation or …See details»